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Lactobacilli and bifi dobacteria are most commonly encountered in the dairy industries, either existing naturally in 
milk or inoculated as starters in fermented dairy products. Recent research suggests that fermented dairy products 
are a cocktail of bioactive ingredients. The objective of our study was to evaluate the bioactivity of cell wall fractions 
of Lactobacillus and Bifi dobacterium grown in reconstituted skimmed milk, and the possibility of intra- and 
extracellular extracts of these bacteria for applications in foods and beyond. Intracellular and extracellular extracts 
of Lactobacillus and Bifi dobacterium showed inhibitory activities against food and dermal pathogens. All strains 
were able to produce inhibitors, such as organic acids, antimicrobial peptides, diacetyl, and hydrogen peroxide. 
Most strains showed higher production of extracellular than intracellular inhibitors (P<0.05). Meanwhile, all 
strains were able to produce hyaluronic acid, lipoteichoic acid, peptidoglycan, neutral sphingomyelinase and acid 
sphingomyelinase at concentrations applicable for cosmeceutical application. Findings from our study demonstrated 
that inhibitors and bioactives from lactobacilli and bifi dobacteria have the potential to be developed into formulations 
for food and non-food applications.
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Lactobacilli and bifi dobacteria are among the most common genera associated with probiotic 
properties, isolated from raw milk and fermented dairy products (FAO/WHO, 2006). These 
bacteria have been well documented for their gastrointestinal health benefi ts of a variety 
of fermented foods. In parallel, emerging clinical studies suggest that probiotics in foods 
might exert their benefi ts beyond the gut, extending to non-food applications, including 
cosmeceuticals. This motivates researchers alike to investigate the functionality and potential 
of these bacteria in foods and cosmeceutical applications.
Milk provides nutrient rich medium for the growth of probiotics, thereby various 
inhibitors and bioactives are produced and subsequently accumulated in the growth medium 
upon milk fermentation. Lactobacillus and Bifi dobacterium rapidly produce desirable 
inhibitors that exert strong antagonistic activity against food-borne pathogens, and thus 
widely applicable to food industries. These inhibitors include organic acids, antimicrobial 
peptides, diacetyl, and hydrogen peroxide (H2O2). Organic acids have been used for decades 
as food additives for preventing food deterioration. Antimicrobial peptides have also received 
increasing attention as biopreservatives to inhibit competitive microfl ora, particularly in 
cheese. Furthermore, diacetyl and H2O2 can also contribute to the overall antagonistic activity 
against food-borne pathogens. Meanwhile, current studies have postulated the use of 
inhibitors from lactobacilli and bifi dobacteria beyond food applications. The benefi cial 
effects derived from bioactives produced by these bacteria, such as hyaluronic acid (HA), 
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peptidoglycan (PG), lipoteichoic acid (LTA), and sphingomyelinase, may strengthen the skin 
defence system. However, limited studies have been carried out to evaluate such potentials. 
Thus, the aim of our present study is to evaluate the ability of Lactobacillus and Bifi dobacterium 
grown in reconstituted skimmed milk to produce compounds that are inhibitive against food 
and dermal pathogens, and benefi cial for skin health.
1. Materials and methods
1.1. Bacterial cultures
Klebsiella pneumoniae, Escherichia coli, Staphylococcus aureus, S. epidermidis, Micrococcus 
luteus, Pseudomonas aeruginosa, and Streptococcus pyogenes were obtained from the culture 
collection of Bioprocess Division, School of Industrial Technology, Universiti Sains Malaysia 
(USM) (Penang, Malaysia). These bacteria were grown in trypticase soy broth (Hi media, 
India), except for M. luteus, which was grown in nutrient broth (Merck, Germany), at 37 °C 
for 18 h. Pure cultures of Lactobacillus casei BT 0442 and BT 1268, L. plantarum FTDC 
8943, L. fermentum BT 8848, BT 8219, FTDC 8513 and FTDC 8312, L. acidophilus FTDC 
2333, FTDC 4356, and FTDC 314, L. bulgaricus FTDC 8611 and FTDC 8913, Bifi dobacterium 
longum FTDC 8643 and FTDC 8843, and B. bifi dum FTDC 2142 were obtained from the 
culture collection of Bioprocess Division, School of Industrial Technology, USM (Penang, 
Malaysia). All strains were activated successively three times in de Man Rogosa Sharpe 
(MRS) broth (Hi media, India) at 37 °C for 24 h prior to use. Sterile MRS broth supplemented 
with 0.15% (w/v) L-cysteine hydrochloride was used for the propagation of Bifi dobacterium.
1.2. Determination of cell growth and pH
Activated cell cultures of 1% (v/v) of Lactobacillus or Bifi dobacterium were inoculated into 
8% (w/v) RSM and fermented at 37 °C. Bacterial growth in RSM at 0, 4, 8, 12, 16, 20, and 
24 h were determined via the pour plate method. Strains that presented statistically higher 
growth in the stationary phase were selected for further analyses.
Activated cell cultures of 1% (v/v) of Lactobacillus or Bifi dobacterium were inoculated 
into 8% (w/v) RSM and fermented for 20 h. pH was determined using DELTA 320 pH meter.
1.3. Preparation of extracellular and intracellular extracts and cell wall fractions
Cells were collected by centrifugation (12 000×g) for 15 min at 4 °C. The supernatant was 
designated as extracellular extract. The pellet obtained was suspended in PBS buffer (pH 7.4) 
and sonicated (20 kHz) in an ice bath for 15 min prior to centrifugation. The supernatant and 
pellet obtained were designated as intracellular extract and cell wall fraction, respectively. 
All samples were stored at –20 °C prior to the determination of inhibitors and bioactives.
1.4. Determination of extracellular and intracellular antimicrobial activities
The antimicrobial activities were determined using the disc diffusion method, based on the 
diameter of the inhibition zone around each paper disc. The unfermented RSM and fermented 
RSM treated with heat (140 °C, 10 min) were used as control and negative control, respec-
tively.
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1.5. Determination of inhibitive compounds
Concentrations of organic acids were determined by High Performance Liquid Chro-
matography (HPLC). HPLC was equipped with a UV absorbance detector set at 220 nm. 
Chromatographic separation was performed on a Luna C18 (2) column (Phenomenex, USA). 
The degassed mobile phase (25 mM KH2PO4, pH 2.5: methanol, 97:3) was used at a fl ow 
rate of 0.3 ml min–1. HPLC-grade acetic and lactic acids (Sigma-Aldrich, Germany) were 
used as standard.
Crude antimicrobial peptides were precipitated using ammonium sulphate. Antimicro-
bial peptides were quantifi ed using Bradford method with bovine serum albumin (Sigma-
Aldrich, Germany) as standard. The absorbance of samples was measured at 595 nm.
H2O2 was determined using the spectrophotometric method (JUAREZ & ELENA, 2004). 
H2O2 (Merck, Germany) was used as standard and absorbance of samples was measured at 
430 nm.
Concentrations of diacetyl were determined based on the colorimetric reaction with 
creatine and α-naphthol. Diacetyl (Sigma-Aldrich, Germany) was used as standard and 
absorbance of samples was measured at 525 nm.
1.6. Determination of bioactives
Hyaluronic acid (HA) was determined using the cetyltrimethylammonium bromide 
turbidimetric method. Purifi ed HA (Sigma-Aldrich, Germany) was used as standard, and 
absorbance of samples was measured at 400 nm.
Sphingomyelinase activities were studied using Amplex® Red sphingomyelinase assay 
kit (Invitrogen, United Kingdom). The fl uorescence of samples was measured at an emission 
of 590 nm and excitation of 540 nm.
Concentrations of LTA were determined using LTA enzyme-linked immunosorbent 
assay (ELISA). A standard curve of LTA was made by using purifi ed LTA of Staphylococcus 
aureus (Sigma-Aldrich, Germany). Absorbance of samples was measured at 450 nm.
Concentrations of PG were determined using human PG ELISA kit (Ruiqi Biological 
Technology, China). Absorbance of samples was measured at 450 nm.
1.7. Statistical analysis
All data were analysed by SPSS Inc. software version 15 (SPSS Inc., USA). One-way 
analysis of variance was performed to analyse the difference between sample means. The 
statistical level of signifi cance was set at α=0.05. The multiple means comparison was 
assessed by Tukey’s test. All data presented were mean values of triplicates, obtained from 
three separate runs.
2. Results and discussion
2.1. Growth and pH
All fi fteen strains were able to grow and reached exponential phase at 8 h to 16 h and 
stationary phase after 20 h (data not shown). All strains recorded maximum viable counts 
ranging between 7.93 and 10.19 log10 CFU ml
–1. Although strains grew well in RSM, most of 
the inhibitors and bioactives were accumulated maximally in the cultured medium during the 
stationary phase (TAN et al., 2011). In order to further elucidate the ability of Lactobacillus 
and Bifi dobacterium in exhibiting benefi cial effects on dermal health, L. plantarum BT 8943, 
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L. fermentum FTDC 8312 and BT 8848, B. longum FTDC 8643, and L. casei BT 1268 that 
showed higher growth in RSM (P<0.05) during the stationary phase (20 h) were selected for 
subsequent analyses.
Our current data showed that the pH of RSM inoculated with Lactobacillus or 
Bifi dobacterium decreased (P<0.05) upon fermentation at 37 °C for 20 h (Table 1). These 
strains have the ability to excrete protons leading to a decrease in the pH of RSM upon 
fermentation (TSENG et al., 1991). RSM fermented by L. fermentum FTDC 8312 had a smaller 
decrease (0.55 units) in pH compared to other strains (P<0.05), and would change 
concentration of H+ by a factor of 3.55. Organic acids are proton donors, leading to the 
lowering in the pH of the surroundings. However, L. fermentum FTDC 8312 produced a 
lower amount of extracellular acetic acid compared to other strains (P<0.05; Table 2); thereby 
a smaller change in pH of RSM was observed. Although B. longum FTDC 8643 is not a lactic 
acid bacteria as the other Lactobacillus spp., a signifi cant change in the pH of RSM was 
observed (P<0.05). Some strains of bifi dobacteria are facilitated by specifi c ABC transpor-
ters and glycosyl hydrolases, thus resulting in a greater production of organic acids and a 
greater drop in the pH of milk (POKUSAEVA et al., 2011).
Table 1. Changes in pH of 8% (w/v) RSM prior and upon fermentation by Bifi dobacterium 
and Lactobacillus for 20 h
Strain
pH value1
Time (h)
0 20 Δ[H+]factor
L. plantarum BT 8943 5.70±0.00aA 4.75±0.21dB 8.91a
L. fermentum BT 8848 5.70±0.00aA 4.85±0.07bB 7.08b
B. longum FTDC 8643 5.65±0.07aA 4.80±0.00cB 7.08b
L. casei BT 1268 5.30±0.00aA 4.75±0.07dB 7.08b
L. fermentum FTDC 8312 5.30±0.00aA 5.05±0.07aB 3.55c
1Results are expressed as mean±standard deviation (n=3). abcdMeans in the same column with different lowercase 
superscript letters are signifi cantly different (P<0.05). ABMeans in the same row with different uppercase superscript 
letters are signifi cantly different (P<0.05)
2.2. Intracellular and extracellular antimicrobial activities
In order to be used as food preservatives or components in skin care products, Lactobacillus 
and Bifi dobacterium are required to specifi cally inhibit the growth of foodborne and dermal 
pathogens. Intracellular and extracellular extracts from all strains showed inhibitory activities 
against K. pneumoniae, P. aeruginosa, E. coli, and S. aureus, which are important causative 
agents in food poisoning. In addition, intra- and extracellular extracts from all strains also 
inhibited S. pyogenes and M. luteus that are commonly associated with skin wounds. 
Intracellular extract of L. casei BT 1268 showed greater inhibitory activity against E. coli and 
P. aeruginosa compared to other strains (P<0.05), with the inhibition zone ranging from 
8.10–9.25 mm. However, it was less effective against M. luteus compared to other pathogens 
(P<0.05). Meanwhile, L. fermentum FTDC 8312 showed a greater extracellular antimicrobial 
activity against S. epidermidis, M. luteus, and P. aeruginosa compared to the other strains 
(P<0.05), with the inhibition zone ranging from 8.25–10.00 mm.
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Table 2. Concentration of inhibitive compounds from intracellular and extracellular extracts of Bifi dobacterium 
and Lactobacillus upon fermentation in 8% (w/v) RSM for 20 h
Strain
Concentrations, mg ml–1
Intracellular
(I)
Extracellular
(E)
Difference,
(E–I)/ E×100 (%)
Acetic acid
L. plantarum BT 8943 0.779±0.146aB 2.413±0.266aA 67.72
L. fermentum BT 8848 0.378±0.151bB 2.292±0.171aA 83.51
B. longum FTDC 8643 0.821±0.121aB 2.496± 0.171aA 67.11
L. casei BT 1268 0.381±0.124bB 1.561±0.248bA 75.59
L. fermentum FTDC 8312 0.351±0.921bB 2.107±0.289abA 83.34
Antimicrobial peptides
L. plantarum BT 8943 0.351±0.226aB 0.581±0.090aA 39.59 
L. fermentum BT 8848 0.300±0.167aB 0.432±0.189bA 30.55
B. longum FTDC 8643 0.211±0.193bB 0.440±0.322bA 52.05
L. casei BT 1268 0.320±0.506aB 0.571±0.360aA 43.96
L. fermentum FTDC 8312 0.320±0.174aA 0.381±0.417bA –
Diacetyl
L. plantarum BT 8943 0.787±0.424cB 3.167±0.448bcA 75.15
L. fermentum BT 8848 1.086±0.279cB 2.432±0.382cdA 55.35
B. longum FTDC 8643 1.164±0.279cB 2.354±0.336dA 50.55
L. casei BT 1268 7.090±0.810aB 9.343±0.323aA 24.11
L. fermentum FTDC 8312 5.436±1.109bA 3.797±0.305bA –
Results are expressed as mean±standard deviation (n=3). abcdMeans in the same column with different lowercase 
superscript letters are signifi cantly different (P<0.05). ABMeans in the same row with different uppercase superscript 
letters are signifi cantly different (P<0.05). – Means no signifi cant difference and/or intracellular > extracellular. 
Control (unfermented milk) and negative control (heat treated fermented RSM): not detected
2.3. Inhibitive compounds
Organic acids have a long history of use as food additives and/or accumulate as a consequence 
of the addition of starter culture in dairy products prior to the fermentation process. Organic 
acid sprays have also been utilized as sanitizers in meat processing, where there is a potential 
of being contaminated with foodborne pathogens. In the current study, a notable amount of 
organic acids, such as lactic and acetic acids; were detected in both intracellular and 
extracellular extracts of all strains. Concentrations of lactic and acetic acids in the extracellular 
extract were 79% and 67% higher, respectively, than intracellular extracts of all strains 
(P<0.05). Lactobacillus and Bifi dobacterium produce lactic and acetic acids inside the cell, 
and transport them out from the cell through the cellular membrane to maintain intracellular 
homeostasis (SURVILA et al., 2011). While extracellular extracts from strains of Lactobacillus 
and Bifi dobacterium contained equal concentrations of lactic acid (data not shown), the 
concentration of extracellular acetic acid from B. longum FTDC 8643 was 37.4% higher than 
from L. casei BT 1268 (P<0.05; Table 2). The presence of fructose-6-phosphoketolase in B. 
longum FTDC 8643 allows the former to ferment carbohydrates and produced more acetic 
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acid via the bifi dus pathway. Lactic and acetic acids are strong inhibitors of most Gram-
negative and neutrophilic bacteria, such as S. aureus. The inhibitory activities of these acids 
have been associated with the ability to dissociate and release high amount of free H+ in a 
relative low acid stress environment, resulting in the membrane disruption of pathogenic 
bacteria. Our study demonstrated that all strains produced lactic acid at concentrations of 
0.2–0.4% (w/v). Lactic acid was shown to modulate the barrier function of stratum corneum 
(BERARDESCA et al., 1997). Topical application of 0.5% acetic acid was also shown to 
eliminate P. aeruginosa from the burn wounds of patients (SLOSS et al., 1993). Although a 
higher concentration of acetic acid is required to eliminate P. aeruginosa, inhibitory action 
against P. aeruginosa could be increased via synergism with lactic acid (TANNER & JAMES, 
1992). Summing it up, the preliminary fi ndings in this study suggest that concentrations of 
lactic and acetic acids produced would be suffi cient for food and cosmeceutical applications.
Antimicrobial peptides are ribosomally synthesized proteinaceous metabolites that exert 
antimicrobial actions against closely related bacteria. Application of antimicrobial peptides 
in foods reduces the intensity of heat treatment needed and could result in foods which are 
richer in nutrition values. Theoretically, bacteria produce antimicrobial peptides as an 
extracellular inhibitive complex. This was in agreement with our current data (Table 2), 
where higher concentrations were observed from extracellular extracts compared to the 
intracellular extracts (P<0.05). Lactobacillus and Bifi dobacterium have been well documented 
to produce antimicrobial peptides which exhibit broad antimicrobial spectrum towards 
closely related Gram-positive bacteria. Other than food applications, topical application of 
3.15% antimicrobial peptides was shown to eliminate dermal pathogens (OH et al., 2006). 
In our current study, Lactobacillus and Bifi dobacterium were able to produce antimicrobial 
peptides at a lower concentration, ranging from 0.3–0.6 mg ml–1. These concentrations may 
not be suffi cient to exert inhibitive actions, but inhibitory effi ciency was reportedly increased 
via synergism with organic acids. Most of the antimicrobial peptides from Lactobacillus and 
Bifi dobacterium interfere with anionic lipids in the membrane structure, thus initiating the 
formation of pores and resulting in increased permeability in the cytoplasmic membrane of 
susceptible cells.
H2O2 is a food preservative, with short lived actions against foodborne pathogens at 
refrigeration temperatures. Its benefi cial role in food applications has been demonstrated in 
dairy industries, as improving the hygiene of dairy products. Most of the strains produced 
equal concentrations of H2O2 in both intra- and extracellular extracts (data not shown). Our 
present study has also shown that L. casei BT 1268 produced higher concentration of H2O2 
compared to the other strains (P<0.05). Lactobacillus strains including L. casei, possess 
specifi c metabolic enzymes including NADH peroxidase, pyruvate and lactate oxidase, 
which aid a higher production of H2O2 (BARRE et al., 2007). H2O2 has the ability to increase 
membrane permeability, of denaturing metabolic enzymes, and of oxidizing lipids in the 
membrane layer of pathogens. All strains produced H2O2 at concentrations ranging from 
0.005–0.03%. It has been reported that H2O2 at a concentration as low as 0.01% inhibited 
bacterial skin infections (OMIDBAKHSH, 2011). Thus, concentrations of H2O2 produced by 
strains in the present study could be suffi cient to exert such an effect.
Diacetyl is a low molecular mass structure, which is excreted out from the cell and 
accumulated in the growth medium without alteration of the membrane layer. Diacetyl has 
been used as dairy fl avouring and biopreservative in a variety of foods, such as cheese and 
yogurt. All strains produced varying concentrations of diacetyl (Table 2), where a higher 
concentration was detected in the extracellular extract than in the intracellular extract 
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(P<0.05). Diacetyl can be synthesized via intermediary α-acetolactate, transported out from 
the cell, and leading to a higher concentration of diacetyl detected in the extracellular extract. 
Additionally, the presence of specifi c citrate transporters in Lactobacillus also facilitates the 
production of diacetyl (QUINTAS et al., 2008). This was in tandem with our results, where 
higher concentrations of diacetyl were produced by Lactobacillus spp. compared to B. longum 
FTDC 8643 (P<0.05). Diacetyl has been shown to inhibit E. coli and S. aureus via the 
inhibition of arginine utilization in the periplasmic space. Our results showed that all strains 
were able to produce diacetyl at concentrations ranging from 2.0–10.0 mg ml–1. Diacetyl is 
effective against Gram-negative bacteria at concentrations as low as 0.2 μg ml–1 (WILLIAMS-
CHAMPBELL, 1998). Thus, the concentrations of diacetyl produced by all strains could exert 
effective inhibition against foodborne and dermal pathogens.
2.4. Bioactives
Hyaluronic acid (HA) has been used as an ideal bio-component in dermatological applications. 
The application of cosmetic products containing HA could enhance moisture locking 
functions. Lactobacillus strains and B. longum FTDC 8643 were able to produce HA (Fig. 
1A). HA is produced intracellularly, where two UDP-activated sugars are catalyzed by 
hyaluronan synthase within the cytosol. HA formed is then transported to the extracellular 
matrix via ABC transporters. This was in tandem with our current data, where most of the 
strains showed higher production of HA in the extracellular extract compared to the 
intracellular extract (P<0.05). The transport effi ciency of cellular membrane has a greater 
infl uence on the release of intracellular HA (VAN DE RIJN, 1983). Thus, varying concentrations 
of HA observed in Lactobacillus strains and B. longum FTDC 8643 could be due to the 
different degrees of transport effi ciency in the cellular membrane. HA at a concentration as 
low as 10 μg ml–1 reportedly increased the production of proinfl ammatory cytokines TNF-α 
and IL-8 during the early stage of wound healing process (BROWN & JONES, 2005). Therefore, 
it is postulated that the concentrations of HA produced by our strains (0.3–0.7 mg ml–1) could 
be suffi cient to provide possible dermal benefi ts.
Sphingomyelinase is a sphingomyelin-specifi c phospholipase C that catalyzes the 
hydrolysis of sphingomyelin to generate phosphocholine and ceramide. Ceramides are major 
structural components in the horny layer, and play a fundamental role in providing the 
cutaneous permeability barrier function. All strains exhibited both neutral sphingomyelinase 
(N-SMase) and acid sphingomyelinase (A-SMase) activities. Extracellular SMase activities 
was higher than that of intracellular SMase activities (P<0.05). SMase localized within cells 
and can be secreted out to the extracellular space, generating a higher level of extracellular 
SMase activity. Lactobacillus casei BT 1268 exhibited higher N-SMase activity compared to 
the other strains (P<0.05; Fig. 1B), whereas all strains exhibited equal A-SMase activity (data 
not shown). Although N-SMase activity varies among strains, L. casei is one of the 
Lactobacillus spp. capable of presenting a higher level of N-SMase activity (DI MARZIO et al., 
2001). C24- and C16-ceramides could also be generated by the activation of both N-SMase 
and A-SMase. SMase at a concentration as low as 1.0 mU ml–1 increased ceramide formation 
and induced interleukin 6 production in human fi broblasts (STANLEY et al., 1995). All strains 
exhibited both N-SMase and A-SMase activities, with concentrations ranging from 0.4–0.6 
mU ml–1 and 0.1–2.4 mU ml–1, respectively. We believe these concentrations could be 
suffi cient to promote benefi cial dermal effects.
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Fig. 1. Concentration of bioactives in extra- and intracellular extracts and cell wall fraction of Bifi dobacterium 
and Lactobacillus upon fermentation in 8% (w/v) RSM at 37 °C for 20 h. A. Hyaluronic acid. B. Neutral 
sphingomyelinase activity C. Lipoteichoic acid. abcdeMeans in the same series with different lowercase superscript 
letters are signifi cantly different (P<0.05). ABMeans in the same category with different uppercase superscript 
letters are signifi cantly different (P<0.05). Control (unfermented milk) and negative control (heat treated 
fermented RSM): not detected. : L. plantarum BT 8943; : L. fermentum BT 8848; 
: B. longum FTDC 8643; : L. casei BT 1268; : L. fermentum FTDC 8312.
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LTA is present exclusively in the cell wall of Gram-positive bacteria that contributes to 
infl ammatory and immune homeostasis on skin. LTA from S. epidermidis inhibited IL-8 and 
IL-1α production of keratinocytes, and infl ammation triggered by TLR2-dependent injuries. 
LTA has also been demonstrated as a stimulatory component for the expression of human 
beta defensin-2 (hBD-2), which could strengthen the skin defence system. Lactobacillus 
strains and B. longum FTDC 8643 showed varying concentrations of LTA in the cell wall 
fraction, and in extracellular and intracellular extracts (Fig. 1C). Despite being the abundant 
component present in the cell wall of Gram-positive bacteria, LTA can also be released 
spontaneously into the culture medium during growth (POLLACK et al., 1992). This agreed 
with our current data, where higher concentration of LTA was detected in the cell wall 
fraction, with smaller amounts detected in both extracellular and intracellular extracts 
(P<0.05). Production of LTA was strain dependent. L. fermentum FTDC 8312 contained a 
signifi cantly higher concentration of LTA in the cell wall fraction compared to the other 
strains (P<0.05). Little information is available on the biosynthesis of LTA from Lactobacillus 
and Bifi dobacterium. However, L. fermentum ATCC 14931 possess dlt operon containing 
dltD (EMBL source EEI22757.1) that is essential for D-alanylation during LTA biosynthesis 
(DEBABOV et al., 2000). Although this may be strain specifi c, we postulate that L. fermentum 
FTDC 8312 may possess the gene encoding dltD leading to increased production of LTA. 
More work is needed to justify this fi nding. Our current study demonstrated that all strains 
produced LTA at concentrations of 180–530 ng ml–1. LTA at a concentration as low as 100 ng 
ml–1 increased the stimulation of antimicrobial peptides in human epithelial cells (NEUMAN et 
al., 2010). Additionally, LTA from Lactobacillus had low cytotoxicity compared to LTA 
isolated from pathogenic bacteria. Therefore, the concentrations of LTA produced by our 
strains would be suffi cient and safe for the expression of human β-defensins and may 
subsequently contribute to enhance skin defence.
PG from bacteria has been reported to induce hBD-2 expression in skin cells. PG is one 
of the pathogen-associated molecular patterns that results in an induction of defence-related 
genes and elevation of the barrier function in epidermal keratinocytes. All strains contained 
equal amounts of PG in the cell wall fraction, despite the differences in genera (data not 
shown). Furthermore, a lower concentration of PG was also detected in both extra- and 
intracellular extracts. This may be due to the acid-insoluble PG turnover that was released 
into the culture medium via lytic activity (FREHEL & RYTER, 1979). Our strains were able to 
produce PG at concentrations ranging from 300 to 410 ng ml–1. PG at a lower concentration 
of 2.5 μg ml–1 increased the expression of the LL37 in keratinocytes, leading to a protective 
effect in psoriatic skin lesions (RUIZ-GONZALEZ et al., 2009). Although a higher concentration 
of PG is required to stimulate the cellular immunity response and LL37 in keratinocytes, 
an induction response has been reported via synergism with LTA. Considering that our 
strains produced PG and LTA at concentrations ranging from 180 to 530 ng ml–1, we 
postulated that this concentration could exert a stimulative cellular immunity response for 
skin defence.
3. Conclusion
Results illustrated the potential use of cell wall fractions and intra- and extracellular extracts 
of lactobacilli and bifi dobacteria grown in milk, as inhibitors and/or bioactives for food and 
cosmeceutical applications. All strains were able to produce inhibitors and bioactives at 
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concentrations that could inhibit the growth of bacteria that cause food-borne illnesses and 
dermal infections, and improve cellular immunity responses needed for skin defence.
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